Among the top five most hyper-methylated promoters, FGF19 is related to HCC tumor promotion [22], FGF4 is related to HCC drug response [23], and HLX is involved in normal liver development [24]. The gene discussed is FGF19; the disease is hepatocellular carcinoma.